Teva Pharmaceutical Industries Ltd has no dividend payments on record. Any capital returned to shareholders comes through share repurchases — shown below.
Capital returns
Net buybacks = repurchases − stock issuance, fiscal-year cash flows. SBC shown for dilution context.
Total Shareholder Yield (TTM)
0.0%
Dividends 0.0% + Net buybacks 0.0%
Net Buyback (TTM)
€0
Gross €0 − Issuance €0
SBC (TTM)
€137M
Share-based compensation, dilution driver
Net share-count change % / yr
No splits on record.